Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.
Coelho-Silva JL, Carvalho LE, Oliveira MM, Franca-Neto PL, Andrade AT, Lima AS, Bezerra MF, Lima MM, Neves MA, Fonseca JM, Barros-Correia MC, Machado CG, Bezerra MA, Matos DM, Lucena-Araujo AR.
Coelho-Silva JL, et al. Among authors: andrade at.
Br J Haematol. 2017 Feb;176(3):498-501. doi: 10.1111/bjh.13971. Epub 2016 Feb 23.
Br J Haematol. 2017.
PMID: 26914377
Free article.
No abstract available.